Form 4 for TMCI TREACE MEDICAL CONCEPTS, INC.
Accepted 2022-03-10 00:00:00 ET · period of report 2022-03-08 · accession 0001567619-22-006730 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-10 | 2022-03-08 | TMCI | Treace John T. | CEO, Dir, 10% | A - Grant | $0.00 | +33.9K | 5.46M | +0.6% | $0 |
| DM | 2022-03-10 | 2022-03-08 | TMCI | Treace John T. | CEO, Dir, 10% | A - Grant | $0.00 | +261.4K | 20.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-08 | A | A | 33,875 | $0.00 | 5,456,455 | D | — | — | (F1) Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026? subject to Reporting Person's providing continued service to Issuer through each vesting date. (F2) Includes 33,875 RSUs. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-03-08 | A | A | 240,566 | $0.00 | 240,566 | D | $19.15 · — to 2032-03-08 | 240,566 Common Stock | (F3) The stock option will vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026; subject to Reporting Person's providing continued service to Issuer through each vesting date. |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-03-08 | A | A | 20,884 | $0.00 | 20,884 | D | $21.07 · — to 2027-03-08 | 20,884 Common Stock | (F3) The stock option will vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026; subject to Reporting Person's providing continued service to Issuer through each vesting date. |